INTUITIVE SURGICAL (ISRG)
Health Care/ Health Care Equipment
Company announced 2Q earnings last week which exceeded expectations -it managed to increase gross margin by eliminating distributors and sell more directly.
In 2019 Expected revenue +16.5%, EPS + 14.3%, EBITDA margin +3.4 p.p. (38.5%)
In 2020 Expected revenue +23.1%, EPS + 13.7%, EBITDA margin -0.5 p.p. (38.0%)
12M Tgt Px is USD 571.88 (Bloomberg). Since last Friday analyst increased Target Px above USD 600
Company doesn't pay dividend.
We are looking to enter long position at current levels - 2.0% portfolio exposure.
Company announced 2Q earnings last week which exceeded expectations -it managed to increase gross margin by eliminating distributors and sell more directly.
In 2019 Expected revenue +16.5%, EPS + 14.3%, EBITDA margin +3.4 p.p. (38.5%)
In 2020 Expected revenue +23.1%, EPS + 13.7%, EBITDA margin -0.5 p.p. (38.0%)
12M Tgt Px is USD 571.88 (Bloomberg). Since last Friday analyst increased Target Px above USD 600
Company doesn't pay dividend.
We are looking to enter long position at current levels - 2.0% portfolio exposure.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.